In chronic hepatitis B virus (HBV) The reason for the more extensive expression of HBcAg in the cytoplasm with polyclonal antibody than with monoclonal antibody remains unclear. Theoretically, the polyclonal antibody might recognise plural antigenic determinants and then react more strongly with the corresponding antigen. It has also been shown that the rabbit polyclonal antibody from Dako Corporation used in the present study contained both anti-HBc and anti-HBe activity.18 Several studies with monoclonal anti-HBc and anti-HBe have also shown a relatively predominant distribution of HBcAg in the nuclei and HBeAg in the cytoplasm. 2 13 The polyclonal antibody used here can probably recognise antigenic components derived from both HBcAg and HBeAg in the liver, and the latter, which is predominantly distributed in the hepatocyte cytoplasm, may be missed with monoclonal anti-HBc. This interesting issue needs to be elucidated by double staining with polyclonal anti-HBc and monoclonal antiHBc or anti-HBe.
In conclusion, both polyclonal and monoclonal antisera showed a quite similar pattern in the distribution of HBcAg in liver, with a predominant localisation of HBcAg in the cytoplasm in HBeAg positive patients with chronic active hepatitis. Semiquantitative analysis, however, showed that polyclonal antiHBc seemed to be more sensitive in detecting HBcAg in the cytoplasm than monoclonal antiHBc. The presence of HBcAg in liver with polyclonal anti-HBc correlated better with the histological features of chronic active hepatitis and the persistence of HBeAg in serum, suggesting that the cytoplasmic expression of HBcAg with polyclonal anti-HBc does not result from non-specific or false positive staining.
